Janssen, B.V.; Theijse, R.; van Roessel, S.; de Ruiter, R.; Berkel, A.; Huiskens, J.; Busch, O.R.; Wilmink, J.W.; Kazemier, G.; Valkema, P.;
et al. Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant Treatment. Cancers 2021, 13, 5089.
https://doi.org/10.3390/cancers13205089
AMA Style
Janssen BV, Theijse R, van Roessel S, de Ruiter R, Berkel A, Huiskens J, Busch OR, Wilmink JW, Kazemier G, Valkema P,
et al. Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant Treatment. Cancers. 2021; 13(20):5089.
https://doi.org/10.3390/cancers13205089
Chicago/Turabian Style
Janssen, Boris V., Rutger Theijse, Stijn van Roessel, Rik de Ruiter, Antonie Berkel, Joost Huiskens, Olivier R. Busch, Johanna W. Wilmink, Geert Kazemier, Pieter Valkema,
and et al. 2021. "Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant Treatment" Cancers 13, no. 20: 5089.
https://doi.org/10.3390/cancers13205089
APA Style
Janssen, B. V., Theijse, R., van Roessel, S., de Ruiter, R., Berkel, A., Huiskens, J., Busch, O. R., Wilmink, J. W., Kazemier, G., Valkema, P., Farina, A., Verheij, J., de Boer, O. J., & Besselink, M. G.
(2021). Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant Treatment. Cancers, 13(20), 5089.
https://doi.org/10.3390/cancers13205089